Clinical Trial Update: Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome [Phase 4]

View source ↗

Summary

This clinical trial update reports a Phase 4 study evaluating the effect of metyrapone on cardiovascular risk factors in patients with adrenal incidentalomas an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Incidentaloma
• Cushing Syndrome

Drugs mentioned

• Metyrapone (Metyrapone)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Adrenal Incidentalomas, Cushing Syndrome | Phase 4 | Status: RECRUITING